Cannabis Player Organigram Clocks Q4 Gross Margin Of 37% On Higher Efficiency Across Cultivation And Higher Recreational Sales, Stock Soars
Cannabis Player Organigram Clocks Q4 Gross Margin Of 37% On Higher Efficiency Across Cultivation And Higher Recreational Sales, Stock Soars
Sales increased 22% year-over-year, primarily due to higher recreational cannabis sales and international sales.On Wednesday, Cannabis producer Organigram Holdings Inc (NASDAQ:OGI) reported fourth-quarter sales of $31.22 million (44.7 million Canadian dollars), up from 36.7 million Canadian dollars, beating the consensus of 42.98 million Canadian dollars.
大麻生產商Organigram Holdings Inc（納斯達克股票代碼：OGI）週三公佈的第四季度銷售額爲3122萬美元（4470萬加元），高於3670萬加元，超過了市場預期的4298萬加元。
The company adds it became Canada's largest cannabis company by market share following the acquisition of Motif Labs subsequent to year-end.
該公司補充說，在年底收購Motif Labs之後，按市場份額計算，它成爲加拿大最大的大麻公司。
Also Read: Organigram Wants To Become Canada's Largest Cannabis Company By Market Share Via $71M Acquisition Deal
另請閱讀：Organigram希望通過7100萬美元的收購協議成爲按市場份額計算的加拿大最大的大麻公司
Sales increased 22% year-over-year, primarily due to higher recreational cannabis sales and international sales.
銷售額同比增長22％，這主要是由於休閒大麻銷售和國際銷售的增加。
Adjusted gross margin was 16.5 million Canadian dollars, or 37% of net revenue, compared to 7.2 million Canadian dollars, or 20%, compared to last year due to efficiency increases across cultivation, manufacturing, and distribution and higher recreational and international sales.
調整後的毛利率爲1650萬加元，佔淨收入的37％，與去年相比爲720萬加元，增長20％，這要歸因於種植、製造和分銷方面的效率提高以及娛樂和國際銷售的增加。
Adjusted EBITDA was 5.9 million Canadian dollars compared to 0.1 million a year ago, primarily attributable to higher net flower revenue, lower general and administrative expenses, and increased gross margins.
調整後的息稅折舊攤銷前利潤爲590萬加元，而去年同期爲10萬加元，這主要歸因於淨花卉收入增加、一般和管理費用減少以及毛利率的提高。
The net loss was 5.4 million Canadian dollars, compared to 26.6 million a year ago, primarily due to higher adjusted gross margins and lower impairment losses in the current quarter.
淨虧損爲540萬加元，而去年同期爲2660萬加元，這主要是由於本季度調整後的毛利率提高和減值損失減少。
"We are pleased with the growth we achieved every quarter in Fiscal 2024, ending the year on a high note with respect to net revenue and adjusted EBITDA," said Greg Guyatt, Chief Financial Officer.
首席財務官格雷格·蓋亞特表示：「我們對2024財年每個季度實現的增長感到滿意，年底淨收入和調整後的息稅折舊攤銷前利潤均表現良好。」
"Efficiency improvements in our operations supported our strong adjusted gross margin in the quarter. Our operational improvements, combined with our recent acquisition of Motif, has laid the foundation for continued growth in Fiscal 2025," Guyatt added.
「我們運營效率的提高爲本季度調整後的強勁毛利率提供了支持。我們的運營改善，加上我們最近對Motif的收購，爲2025財年的持續增長奠定了基礎，」 蓋亞特補充說。
Organigram expects sufficient liquidity to meet strategic and operational objectives in fiscal 2025. The company realized C$9.1 million in annual cost savings through extensive efficiency initiatives in Fiscal 2024.
Organigram預計，有足夠的流動性來實現2025財年的戰略和運營目標。該公司在2024財年通過廣泛的效率舉措每年節省了910萬加元的成本。
Price Action: At last check on Wednesday, OGI stock was up 9.32% at $1.76 during the premarket session.
價格走勢：在週三的最後一次檢查中，OGI股票在盤前交易時段上漲9.32％，至1.76美元。
- General Mills Beats On Q2 Earnings, Stock Slumps On Lackluster Outlook
- 通用磨坊第二季度收益超過預期，股價因前景乏善可陳而暴跌
Photo: Courtesy of Hvoenok and GOR Photo on Shutterstock
照片：由 Hvoenok 和 Shutterstock 上的 GOR 照片提供
